PCRX — PharmaCorp Rx Balance Sheet
0.000.00%
- CA$73.11m
- CA$72.64m
- CA$5.79m
- 73
- 24
- 19
- 32
Annual balance sheet for PharmaCorp Rx, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.98 | 2.73 | 2.24 | 12.9 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | — | — | — | 0.327 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1 | 2.73 | 2.32 | 14.6 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | — | — | 4.02 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Total Assets | 1 | 2.73 | 2.32 | 35.2 |
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.026 | 0.016 | 0.046 | 1.7 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Minority Interest | ||||
| Total Liabilities | 0.026 | 0.016 | 0.046 | 4.87 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 0.974 | 2.72 | 2.27 | 30.3 |
| Total Liabilities & Shareholders' Equity | 1 | 2.73 | 2.32 | 35.2 |
| Total Common Shares Outstanding |